Last edition
News about "AbbVie Apogee acquisition"
AbbVie Completes Acquisition of Apogee Therapeutics
AbbVie completes its acquisition of Apogee Therapeutics, strengthening its immunology pipeline with assets targeting dermatologic, respiratory and inflammatory diseases.
AbbVie Apogee Acquisition | 05/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members